After receiving a PhD in molecular biology form Université de Montréal, Dr. Guy became project leader during an industrial postdoctoral fellowship at Angiogene. He later invented, developed, patented, and licensed a cell and gene therapy approach to treat heart failure. He received a graduate diploma in management from HEC Montréal.
He comes to Charles River with the acquisition of AccelLAB, where he established the scientific program for the preclinical evaluation of medical devices in the fields of cardiology, ENT, orthopedics, and others. As an expert in bioabsorbable scaffolds, he has authored many articles, presented for sponsors in scientific meetings, and was invited as preclinical expert at a workshop for the FDA and a biodegradable metal symposium. Dr. Guy is an active member of the Society of Toxicology.